Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects
Status:
Completed
Trial end date:
2020-02-19
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the effects of nesiritide to placebo administered by a
continuous IV infusion over 48 hours for the treatment of insulin resistance in healthy,
obese, insulin resistant individuals.
Phase:
Phase 1
Details
Lead Sponsor:
Translational Research Institute for Metabolism and Diabetes, Florida